Biotechnology
Pharmaceutical
Health
Flexion Therapeutics
$10.919876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.54 (-4.72%) Today
$0.00 (0.00%) As of 4:36 PM EDT after-hours
Why Robinhood?
You can buy or sell FLXN and other stocks, options, ETFs, and crypto commission-free!
About FLXN
Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. Read More It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.
Employees
272
Headquarters
Burlington, Massachusetts
Founded
2007
Market Cap
435.02M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
628.25K
High Today
$11.51
Low Today
$10.90
Open Price
$11.46
Volume
357.72K
52 Week High
$27.84
52 Week Low
$9.65
Collections
Biotechnology
Pharmaceutical
Health
Therapy
Technology
2014 IPO
US
North America
FLXN News
Price Paid on Robinhood
29% Lower
Right Now
52 Week Low
$9.90
Average Price Paid
$15.47
52 Week High
$29.10
Analyst Ratings
89%
of 9 ratings
Buy
89%
Hold
11%
Sell
0%
FLXN Earnings
-$1.43
-$0.75
-$0.06
$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, After Hours